The Middle East & Africa hydrolyzed bovine collagen market size is expected to reach a valuation of US$ 42.4 million in 2023. It is estimated to witness a CAGR of around 9.4% in the review period 2023 to 2033.
The Middle East & Africa hydrolyzed bovine collagen industry is likely to surpass a valuation of about US$ 104.4 million by 2033. It is anticipated to create an absolute dollar opportunity of US$ 62 million in the forecast period.
Preferences have changed in favor of clean-label, natural components. It has led to an inclination from chemical additives. Modern consumers might move toward organically sourced products, including hydrolyzed bovine collagen.
Origins of collagen resonate with people seeking healthy and naturally processed products. Collagen comes from organic sources that include bovine hides or bones. Hence, as customers become more mindful of their health and examine ingredient lists, demand might elevate.
Hydrolyzed bovine collagen demand has been significantly increased by trends in health and well-being. Collagen is considered a crucial protein to maintain the health of one’s skin, joints, and bones.
It is hence expected to make it a popular product for those trying to maintain their health. Collagen supplements can be a unique way to assist several biological functions. As more individuals take an active role in their health, demand might rise.
Adaptability and versatility of hydrolyzed bovine collagen might fuel demand across sectors. In addition to vitamins, it has uses in the food & drinks, cosmetics, and pharmaceutical sectors.
Its versatility might increase its appeal among modern consumers. It is also projected to offer producers the chance to use collagen in a range of products, which has surged demand.
Both online and offline marketing have helped raise the advantages of collagen. Medical professionals and influencers often use social media platforms to share their knowledge on these products.
As these communications get out to more people, enthusiasm for the product expands. This might help in augmenting demand through 2033.
Escalating demand has also been greatly influenced by social and internet trends. The modern world is highly connected. It is expected to allow information to flow rapidly and create an impact on buyer habits.
Availability of information on hydrolyzed bovine collagen has increased. This is due to rising shift of people to the internet for health & wellness-related information. It is further anticipated to propel demand from a client base that is aware of collagen.
| Attributes | Key Insights |
|---|---|
| Middle East & Africa Hydrolyzed Bovine Collagen Market Estimated Size (2023E) | US$ 42.4 million |
| Projected Market Valuation (2033F) | US$ 104.4 million |
| Value-based CAGR (2023 to 2033) | 9.4% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The Middle East & Africa hydrolyzed bovine collagen industry showcased a steady CAGR of 11.0% in the historical period between 2018 and 2022. It is anticipated to witness a decent CAGR of about 9.4% in the forecast period.
Hydrolyzed bovine collagen demand is expected to rise dramatically in the forecast period, finds Future Market Insights (FMI). The product is anticipated to help prevent the adverse effects of low collagen level. Reduced collagen production is common in those who eat a lot of refined or sugary carbs, as well as in chain smokers.
Several companies are estimated to conduct research work to find out more about how collagen derived from bovines can help elevate the level. At the same time, hydrolyzed bovine collagen is anticipated to be used for reducing the symptoms of osteoarthritis.
As per the World Health Organization (WHO), around 73% of individuals older than 55 years were affected by osteoarthritis in 2019. WHO further predicted that since 1990, a surge of about 113% was observed in the rate of osteoarthritis cases globally in the same year. Rising incidence of the disease is hence projected to aid consumption of hydrolyzed bovine collagen.
Millennial consumers are expected to look for new cosmetics products that can enhance aging skin by increasing the quantity and quality of collagen. Key companies are hence set to launch innovative products to attract more customers. They are using hydrolyzed bovine collagen in creams, moisturizers, and serums to refine collagen fibers and skin’s elasticity.
In several animal studies, hydrolyzed bovine collagen has exhibited to avert bone loss. It is projected to help battle osteoporosis. A study published in the National Library of Medicine found that about 40.9% patients out of 120 were osteopenic, while around 48.3% were osteoporotic. The study was conducted in a Dubai-based primary health care center.
| Attributes | Factors |
|---|---|
| Latest Trends |
|
| Growth Obstacles |
|
| Upcoming Opportunities |
|
Principal Consultant
The below table showcases revenues in terms of important countries in the Middle East and Africa. Türkiye and South Africa might be the dominant markets by 2033, with sizes of US$ 23.2 million and US$ 20.7 million, respectively.
United Arab Emirates, with a size of US$ 20 million by 2033, is anticipated to be the next prominent country, followed by Israel and Saudi Arabia. The report mentions that these leading 5 countries would create new avenues for growth in the forecast period.
| Country | South Africa |
|---|---|
| Value-based CAGR (2023 to 2033) | 9.4% |
| Market Size (2033) | US$ 20.7 million |
| Absolute Dollar Opportunity (2023 to 2033) | US$ 12.3 million |
| Country | Saudi Arabia |
|---|---|
| Value-based CAGR (2023 to 2033) | 9.2% |
| Market Size (2033) | US$ 3.7 million |
| Absolute Dollar Opportunity (2023 to 2033) | US$ 2.1 million |
| Country | United Arab Emirates |
|---|---|
| Value-based CAGR (2023 to 2033) | 9.3% |
| Market Size (2033) | US$ 20 million |
| Absolute Dollar Opportunity (2023 to 2033) | US$ 11.8 million |
| Country | Türkiye |
|---|---|
| Value-based CAGR (2023 to 2033) | 9.3% |
| Market Size (2033) | US$ 23.2 million |
| Absolute Dollar Opportunity (2023 to 2033) | US$ 13.7 million |
| Country | Israel |
|---|---|
| Value-based CAGR (2023 to 2033) | 8.9% |
| Market Size (2033) | US$ 4.9 million |
| Absolute Dollar Opportunity (2023 to 2033) | US$ 2.8 million |
United Arab Emirates hydrolyzed bovine collagen market is expected to witness a CAGR of 9.3% in the forecast period. It registered a steady CAGR of 10.8% in the historical period from 2018 to 2022.
In the United Arab Emirates, where consumers are actively looking for products to improve their appearance and wellbeing, the cosmetics and nutraceutical sectors are expanding. It is commonly known that hydrolyzed collagen can make the skin suppler.
It is also capable of lessening wrinkles and encouraging a young appearance. This might fit with the country’s consumers’ preferences, which are centered on beauty.
Use of social networking sites and internet advertising has raised knowledge of the product. On Instagram, influencers and celebrities frequently advertise these goods. This is set to help in generating talk about their advantages and enticing customers to buy them.
In July 2023, for instance, Dubai welcomed JUJU Lifestyle, an established health and wellness business famous for its TikTok viral brand of effervescent pills. JUJU GlutaFair and JUJU Collagen are now conveniently available for purchase in Dubai.
As per the company, consumers will be able to order its products from anywhere in the United Arab Emirates. It is committed to helping people maintain their wellbeing. It also aims to help them adopt self-care practices that are enjoyable and practical.
Türkiye hydrolyzed bovine collagen market is anticipated to create an incremental opportunity of US$ 13.7 million in the review period. It is projected to witness a CAGR of 9.3% in the same period.
Türkiye has been a well-liked location for medical travel. It has been drawing patients looking for wellness procedures and aesthetic surgeries. Collagen supplements are set to be a complement to wellness options offered by the nation's medical tourism sector.
Food in Türkiye also includes dishes that are high in protein and collagen-boosting components. Bone broths and stews with lots of gelatin are gaining impetus.
Consumers are more likely to embrace and find the idea of adding collagen to foods & beverages appealing. This is because it is consistent with the culinary heritage.
In Türkiye, e-commerce is expanding significantly. It is hence giving customers a simple way to access and buy items containing hydrolyzed bovine collagen. Online marketplaces might make it possible for domestic and foreign firms to reach a larger customer base.
Growing middle class in Türkiye has more discretionary income. This might allow people to spend on goods with positive effects on their health and appearance.
Needs of this sector can be met by supplements made from hydrolyzed bovine collagen. These are estimated to be marketed as premium health goods in the country.
For instance, in July 2022, one of the most well-known collagen products in the world, Vital Proteins, was made available to Türkiye consumers by Nestlé Health Science Türkiye. Vital Proteins welcomed its customers to find their inner light as it entered the market.
The company introduced its Vital Proteins Collagen Peptides range. It aims to help support the requirement for collagen. Jennifer Aniston, a well-known actress worldwide, is the brand's spokesperson.
Israel hydrolyzed bovine collagen market is likely to surpass a valuation of about US$ 4.9 million by 2033. It registered a decent CAGR of 10.2% during the historical period.
Individuals in Israel frequently take an integrated approach to wellness, which takes into account mental, emotional, and spiritual well-being. Products made from hydrolyzed bovine collagen can be viewed within this framework as an all-encompassing way to improve physical wellbeing.
Due to its residents' extensive global connections, Israel is open to embracing global trends in both health and aesthetics. Customers who seek cutting-edge health goods are expected to embrace hydrolyzed bovine collagen as it gains popularity globally.
Israel has also established a track record as a top location for wellness and rejuvenation travel, especially for medical procedures. Possible advantages of hydrolyzed bovine collagen for youthful skin and anti-aging might suit the tastes of visitors who are health-conscious.
Opportunities for adding hydrolyzed bovine collagen into different foods & beverages are provided by Israel's rich culinary traditions and developing food scene. Consumers might find collagen-enriched foods more enticing since they can adapt to regional tastes and preferences.
FLORA Ventures, an Israel-based venture capital company, formed an additional US$ 80 million investment for sustainable agrifood entrepreneurs. The business would fund early-stage entrepreneurs from Europe and Israel. It would be provided to those who are constructing a system for growing food and other agricultural goods that is healthier, more resilient, and sustainable.
It has already made its initial purchase in Arrakis Bio. It is an Israel-based firm operating in stealth mode that is creating a technique to make collagen and gelatin of superior quality without using any animal products.
The below table exhibits type I segment to be the most significant in terms of product through 2033 at 9.2% CAGR. It had registered a decent CAGR of 10.8% in the historical period. It is likely to be followed by the dry segment in the form category. It is set to witness a CAGR of 9.1% in the assessment period.
| Category | Product |
|---|---|
| Sub-category | Type I |
| Forecast CAGR (2023 to 2033) | 9.2% |
| Historical CAGR (2018 to 2022) | 10.8% |
| Category | Form |
|---|---|
| Sub-category | Dry |
| Forecast CAGR (2023 to 2033) | 9.1% |
| Historical CAGR (2018 to 2022) | 10.7% |
In terms of product, the type I segment is projected to witness a high Middle East & Africa hydrolyzed bovine collagen market share through 2033. It is expected to showcase considerable growth at a CAGR of 9.2% in the assessment period. In the historical period, it stood at 10.8% CAGR.
Owing to how closely its structure mimics that of human collagen, it is very compatible with several body processes. Focus on cellular support and skin health in this form of collagen is a primary motivator, appealing to customers looking for focused solutions.
Backed by its well-established advantages, type I collagen is frequently advised by physicians and dermatologists. Its credibility has been strengthened by clinical research.
Studies have showed how well it promotes skin suppleness, minimizes wrinkles, and aids in wound healing. A product that has the support of medical professionals and scientific research might be more readily accepted by consumers.
As type I collagen is compatible with human tissue, it is an important substance in the medical and surgical industries. It is utilized in a range of operations, including bone grafts, tissue engineering, and coverings for wounds. This medicinal use not only increases demand from medical providers but also highlights the effectiveness and adaptability of the collagen type.
Today’s customers have particular food habits such as the keto or paleo diets, that put an emphasis on whole, natural foods. Due to its natural animal origins and compatibility with these lifestyles, type I hydrolyzed bovine collagen fits well with these dietary preferences.
Based on form, the dry category is estimated to dominate the Middle East & Africa hydrolyzed bovine collagen industry by 2033. It is likely to expand at an average CAGR of around 9.1% in the evaluation period. It recorded a CAGR of 10.7% from 2018 to 2022.
The most convenient form of dry hydrolyzed bovine collagen is often in powder form. Desired benefits for health and wellness are promoted by the convenience of use, which stimulates regular use.
Bovine collagen hydrolyzed in dry form can be used in a range of topical and culinary products. Renowned companies are set to add it to several items. Customers looking for collagen solutions that fit their preferences and demands can be catered to by this adaptability.
Dry collagen is considered ideal for busy lifestyles. People who lead active lives, have certain nutritional needs, or want to keep up their fitness regimens are expected to benefit from it.
It is easily transportable in portable containers. This is set to allow millennial consumers to carry it to wherever they go. Dry hydrolyzed bovine collagen can also be added to several recipes without changing the product's consistency, flavor, or texture.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The Middle East and Africa hydrolyzed bovine collagen industry might face intense competition by 2033. Leading companies in the region are focusing on expanding their geographic footprint and product offerings. They are striving persistently to broaden their supply chains and distribution channels.
External firms are also expected to integrate their value chain in the region. This would help them to raise profits. A handful of companies are projected to open new manufacturing facilities in untapped areas to cater to the surging demand.
For instance,
| Attribute | Details |
|---|---|
| Estimated Market Size (2023) | US$ 42.4 million |
| Projected Market Valuation (2033) | US$ 104.4 million |
| Value-based CAGR (2023 to 2033) | 9.4% |
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | Value (US$ million) |
| Key Countries Covered | South Africa, United Arab Emirates, Saudi Arabia, Türkiye, and Israel |
| Key Segments Covered | Product, Form, Application, Country |
| Key Companies Profiled | GELITA AG; Rousselot; Symatese; Collagen Solutions Plc; DSM; Advanced BioMatrix, Inc. |
| Report Coverage | Market Forecast, Company Share Analysis, Competition Intelligence, Market Dynamics and Challenges, and Strategic Growth Initiatives |
The market is likely to top US$ 104.4 million in 2033.
The market is set to expand at 9.4% CAGR from 2023 to 2033.
The market exhibited a CAGR of 11.0% between 2018 and 2022.
Saudi Arabia market is estimated to expand at a CAGR of 9.2% through 2033.
Type I segment might witness a CAGR of 9.2% from 2023 to 2033.
South Africa might exceed a valuation of US$ 12.3 million by 2033.
1. Executive Summary
1.1. Middle East & Africa Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (tons) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (tons) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (tons) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (tons) Analysis and Forecast By Product, 2023 to 2033
5.3.1. Type I
5.3.2. Type II
5.3.3. Type III
5.3.4. Other Product Types
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (tons) Analysis By Form, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (tons) Analysis and Forecast By Form, 2023 to 2033
6.3.1. Dry
6.3.2. Liquid
6.4. Y-o-Y Growth Trend Analysis By Form, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Form, 2023 to 2033
7. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (tons) Analysis By Application, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (tons) Analysis and Forecast By Application, 2023 to 2033
7.3.1. Food & Beverages
7.3.1.1. Functional Foods
7.3.1.2. Functional Beverages
7.3.1.3. Middle East and Africat Processing
7.3.1.4. Dietary Supplements
7.3.1.5. Nutrition Bars
7.3.1.6. Desserts
7.3.1.7. Others
7.3.2. Healthcare
7.3.2.1. Bone Reconstruction
7.3.2.2. Dental Applications
7.3.2.3. Tissue Engineering
7.3.2.4. Cosmetic Surgery & Wound Healing
7.3.2.5. Cardiology
7.3.2.6. Research (Cell Culture, Cell Behavior)
7.3.2.7. Drug Delivery
7.3.3. Others
7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
8. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (tons) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (tons) Analysis and Forecast By Region, 2023 to 2033
8.3.1. Middle East and Africa
8.4. Market Attractiveness Analysis By Region
9. Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (tons) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (tons) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. GCC Countries
9.2.1.2. South Africa
9.2.1.3. Israel
9.2.1.4. Rest of Middle East and Africa
9.2.2. By Product
9.2.3. By Form
9.2.4. By Application
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Form
9.3.4. By Application
9.4. Key Takeaways
10. Key Countries Analysis
10.1. GCC Countries
10.1.1. Pricing Analysis
10.1.2. Market Share Analysis, 2022
10.1.2.1. By Product
10.1.2.2. By Form
10.1.2.3. By Application
10.2. South Africa
10.2.1. Pricing Analysis
10.2.2. Market Share Analysis, 2022
10.2.2.1. By Product
10.2.2.2. By Form
10.2.2.3. By Application
10.3. Israel
10.3.1. Pricing Analysis
10.3.2. Market Share Analysis, 2022
10.3.2.1. By Product
10.3.2.2. By Form
10.3.2.3. By Application
11. Market Structure Analysis
11.1. Competition Dashboard
11.2. Competition Benchmarking
11.3. Market Share Analysis of Top Players
11.3.1. By Regional
11.3.2. By Product
11.3.3. By Form
11.3.4. By Application
12. Competition Analysis
12.1. Competition Deep Dive
12.1.1. GELITA AG
12.1.1.1. Overview
12.1.1.2. Product Portfolio
12.1.1.3. Profitability by Market Segments
12.1.1.4. Sales Footprint
12.1.1.5. Strategy Overview
12.1.1.5.1. Marketing Strategy
12.1.1.5.2. Product Strategy
12.1.1.5.3. Channel Strategy
12.1.2. Rousselot
12.1.2.1. Overview
12.1.2.2. Product Portfolio
12.1.2.3. Profitability by Market Segments
12.1.2.4. Sales Footprint
12.1.2.5. Strategy Overview
12.1.2.5.1. Marketing Strategy
12.1.2.5.2. Product Strategy
12.1.2.5.3. Channel Strategy
12.1.3. Symatese
12.1.3.1. Overview
12.1.3.2. Product Portfolio
12.1.3.3. Profitability by Market Segments
12.1.3.4. Sales Footprint
12.1.3.5. Strategy Overview
12.1.3.5.1. Marketing Strategy
12.1.3.5.2. Product Strategy
12.1.3.5.3. Channel Strategy
12.1.4. Collagen Solutions Plc
12.1.4.1. Overview
12.1.4.2. Product Portfolio
12.1.4.3. Profitability by Market Segments
12.1.4.4. Sales Footprint
12.1.4.5. Strategy Overview
12.1.4.5.1. Marketing Strategy
12.1.4.5.2. Product Strategy
12.1.4.5.3. Channel Strategy
12.1.5. DSM
12.1.5.1. Overview
12.1.5.2. Product Portfolio
12.1.5.3. Profitability by Market Segments
12.1.5.4. Sales Footprint
12.1.5.5. Strategy Overview
12.1.5.5.1. Marketing Strategy
12.1.5.5.2. Product Strategy
12.1.5.5.3. Channel Strategy
12.1.6. Advanced BioMatrix, Inc.
12.1.6.1. Overview
12.1.6.2. Product Portfolio
12.1.6.3. Profitability by Market Segments
12.1.6.4. Sales Footprint
12.1.6.5. Strategy Overview
12.1.6.5.1. Marketing Strategy
12.1.6.5.2. Product Strategy
12.1.6.5.3. Channel Strategy
12.1.7. Cologenesis HealthCare Pvt. Ltd.
12.1.7.1. Overview
12.1.7.2. Product Portfolio
12.1.7.3. Profitability by Market Segments
12.1.7.4. Sales Footprint
12.1.7.5. Strategy Overview
12.1.7.5.1. Marketing Strategy
12.1.7.5.2. Product Strategy
12.1.7.5.3. Channel Strategy
12.1.8. JBS S.A.
12.1.8.1. Overview
12.1.8.2. Product Portfolio
12.1.8.3. Profitability by Market Segments
12.1.8.4. Sales Footprint
12.1.8.5. Strategy Overview
12.1.8.5.1. Marketing Strategy
12.1.8.5.2. Product Strategy
12.1.8.5.3. Channel Strategy
12.1.9. Croda International Plc
12.1.9.1. Overview
12.1.9.2. Product Portfolio
12.1.9.3. Profitability by Market Segments
12.1.9.4. Sales Footprint
12.1.9.5. Strategy Overview
12.1.9.5.1. Marketing Strategy
12.1.9.5.2. Product Strategy
12.1.9.5.3. Channel Strategy
12.1.10. Titan Biotech
12.1.10.1. Overview
12.1.10.2. Product Portfolio
12.1.10.3. Profitability by Market Segments
12.1.10.4. Sales Footprint
12.1.10.5. Strategy Overview
12.1.10.5.1. Marketing Strategy
12.1.10.5.2. Product Strategy
12.1.10.5.3. Channel Strategy
12.1.11. Beyond Biopharma Co., Ltd.
12.1.11.1. Overview
12.1.11.2. Product Portfolio
12.1.11.3. Profitability by Market Segments
12.1.11.4. Sales Footprint
12.1.11.5. Strategy Overview
12.1.11.5.1. Marketing Strategy
12.1.11.5.2. Product Strategy
12.1.11.5.3. Channel Strategy
12.1.12. Tessenderlo Group
12.1.12.1. Overview
12.1.12.2. Product Portfolio
12.1.12.3. Profitability by Market Segments
12.1.12.4. Sales Footprint
12.1.12.5. Strategy Overview
12.1.12.5.1. Marketing Strategy
12.1.12.5.2. Product Strategy
12.1.12.5.3. Channel Strategy
12.1.13. Getinge AB
12.1.13.1. Overview
12.1.13.2. Product Portfolio
12.1.13.3. Profitability by Market Segments
12.1.13.4. Sales Footprint
12.1.13.5. Strategy Overview
12.1.13.5.1. Marketing Strategy
12.1.13.5.2. Product Strategy
12.1.13.5.3. Channel Strategy
12.1.14. Sel Sanayi AS
12.1.14.1. Overview
12.1.14.2. Product Portfolio
12.1.14.3. Profitability by Market Segments
12.1.14.4. Sales Footprint
12.1.14.5. Strategy Overview
12.1.14.5.1. Marketing Strategy
12.1.14.5.2. Product Strategy
12.1.14.5.3. Channel Strategy
13. Assumptions & Acronyms Used
14. Research Methodology
Explore Healthcare Insights
View Reports
Middle East & Africa Hydrolyzed Bovine Collagen Market
